IP Library Granted Patent US 8,802,874
Granted Patent B2
US 8,802,874 · App. 13/936,242 · Granted Aug 12, 2014

Trihydroxy polyunsaturated eicosanoid derivatives

Inventor: Nicos A. Petasis (Hacienda Heights, CA)
Assignee: University of Southern California
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,802,874
App. No.
13/936,242
Granted
Aug 12, 2014
Kind
B2
Abstract

The invention features methods for the preparation of naturally occurring trihydroxy polyunsaturated eicosanoids and their structural analogs. The invention further provides new derivatives and analogs of trihydroxy polyunsaturated eicosanoids that can be prepared according to these methods. The invention also provides compositions and methods using trihydroxy polyunsaturated eicosanoid derivatives for the prevention, amelioration and treatment of a variety of diseases or conditions associated with inflammation or inflammatory response, autoimmune diseases, rheumatoid arthritis, cardiovascular diseases, or abnormal cell proliferation or cancer.

Claims (11)

1. A compound of the general formula

wherein:

A is hydroxy, alkoxy, aryloxy, amino, alkylamino, dialkylamino, or -OM, where M is a cation selected from the group consisting of ammonium, tetra-alkyl ammonium, Na, K, Mg, and Zn; and

R a and R b are independently selected from the group consisting of hydrogen, alkyl, aryl, heteroaryl, acyl, silyl, alkoxyacyl and aminoacyl;

R 2 is hydrogen, alkyl, perfluoroalkyl, aryl and heteroaryl;

R 5 is selected from the group consisting of (i)-(iv) as follows:

i) CH 2 CH(R 6 )CH 2 , where R 6 is hydrogen, alkyl, perfluoroalkyl, aryl, heteroaryl, fluoro, hydroxy or alkoxy;

ii) CH 2 C(R 6 R 7 )CH 2 , where R 6 and R 7 are each independently alkyl, perfluoroalkyl, aryl, or fluoro, or R 6 and R 7 are connected together to form a carbocyclic or heterocyclic ring;

iii) CH 2 OCH 2 , CH 2 C(O)CH 2 , or CH 2 CH 2 ; and

(iv) R 5 is a carbocyclic, heterocyclic, aryl or heteroaryl ring; and

R 8 and R 9 are independently selected from the group consisting of hydrogen, alkyl, perfluoroalkyl, alkoxy, aryl and heteroaryl, or R 8 and R 9 are connected together to form a carbocyclic or heterocyclic ring.

Assignments (3)
CONFIRMATORY LICENSE Recorded Aug 13, 2024
From: UNIVERSITY OF SOUTHERN CALIFORNIA
To: NATIONAL INSTITUTES OF HEALTH
Reel/Frame 068262/0334 →
CONFIRMATORY LICENSE Recorded Mar 24, 2015
From: UNIVERSITY OF SOUTHERN CALIFORNIA
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 035263/0028 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 23, 2015
From: PETASIS, NICOS A.
To: UNIVERSITY OF SOUTHERN CALIFORNIA
Reel/Frame 035227/0872 →
Continuity (7)
Continuation 13407346 · Feb 28, 2012
Division 13042156 · Mar 7, 2011
Continuation 12469423 · May 20, 2009
Continuation 11093757 · Mar 29, 2005
Continuation In Part 10405924 · Apr 1, 2003
Provisional Application 60369543 · Apr 1, 2002
Related Publication 20130296590A1 · Nov 7, 2013